Gut-Busters: IL-17 Ain't Afraid of No IL-23
- PMID: 26488809
- PMCID: PMC4804829
- DOI: 10.1016/j.immuni.2015.10.001
Gut-Busters: IL-17 Ain't Afraid of No IL-23
Abstract
Interleukin-23 (IL-23) is considered a critical regulator of IL-17 in lymphocytes. Whereas antibodies targeting IL-23 ameliorate colitis, IL-17 neutralization exacerbates disease. In this issue, Cua and colleagues and Maxwell and colleagues show that IL-17 maintains intestinal barrier integrity, helping explain this dichotomy (Lee et al., 2015; Maxwell et al., 2015).
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.Immunity. 2015 Oct 20;43(4):739-50. doi: 10.1016/j.immuni.2015.08.019. Epub 2015 Sep 29. Immunity. 2015. PMID: 26431947
-
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.Immunity. 2015 Oct 20;43(4):727-38. doi: 10.1016/j.immuni.2015.09.003. Epub 2015 Sep 29. Immunity. 2015. PMID: 26431948 Free PMC article.
References
-
- Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012;61:1693–1700. - PMC - PubMed
-
- Maxwell J, Zhang Y, Brown W, Smith C, Byrne F, Florino M, Stevens E, Bigler J, Davis J, Rottman J, et al. Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation. Immunity. 2015 in press. - PubMed
-
- McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunol. 2007;8:1390–1397. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources